May 15, 2026
Not a kid anymore
It’s hard not to look at Dexcom and have some very fond memories of how this all started. There is no question that CGM has gone from a toy to one of the most if not the most valuable tools for diabetes management. For those of us who have been there from the start it’s almost nostalgic to look at the company and see it as it really is and not as the kid it once was. That was clear message sent during the company’s investor day.
Here is what stood out for us and it’s . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
